TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Stockholm Vaccin-Lättakut AB
Closing information (x1000 DKK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
2,769
|
2,944
|
2,499 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
-404
|
-207
|
-237 |
| EBITDA |
-404
|
-205
|
-235 |
| Total assets |
692
|
1,301
|
1,490 |
| Current assets |
683
|
1,290
|
1,475 |
| Current liabilities |
238
|
411
|
287 |
| Equity capital |
454
|
889
|
1,202 |
| - share capital |
63
|
66
|
72 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
65.6%
|
68.3%
|
80.7% |
| Turnover per employee |
923
|
981
|
833 |
| Profit as a percentage of turnover |
-14.6%
|
-7.0%
|
-9.5% |
| Return on assets (ROA) |
-58.4%
|
-15.8%
|
-15.8% |
| Current ratio |
287.0%
|
313.9%
|
513.9% |
| Return on equity (ROE) |
-89.0%
|
-23.3%
|
-19.7% |
| Change turnover |
-69
|
665
|
-358 |
| Change turnover % |
-2%
|
29%
|
-13% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.